However, most cancer patients show hypercoagulability, and TF is involved in cancer cell proliferation, survival, angiogenesis, and the epithelial-to-mesenchymal that promotes tumor development (Magnus et al., 2014; Alley et al., 2019). The gene discussed is TF; the disease is cancer.